Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor
about
Pharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant ProteinsGEC1 interacts with the kappa opioid receptor and enhances expression of the receptorRole of mammalian vacuolar protein-sorting proteins in endocytic trafficking of a non-ubiquitinated G protein-coupled receptor to lysosomesHuman delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexinCNIH4 interacts with newly synthesized GPCR and controls their export from the endoplasmic reticulumConserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fishIdentification of proteins that interact with mammalian peptide:N-glycanase and implicate this hydrolase in the proteasome-dependent pathway for protein degradationUbiquitination regulates proteolytic processing of G protein-coupled receptors after their sorting to lysosomesRegulation of anterograde transport of adrenergic and angiotensin II receptors by Rab2 and Rab6 GTPasesFunctional modulation of human delta opioid receptor by neuropeptide FF.Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screeningSmall GTPase regulation of GPCR anterograde traffickingRapid steroid hormone actions initiated at the cell surface and the receptors that mediate them with an emphasis on recent progress in fish modelsPharmacological chaperoning: a primer on mechanism and pharmacologyGABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeperModulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular trafficLuteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum.Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systemsInefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surfaceMutation of SLC35D3 causes metabolic syndrome by impairing dopamine signaling in striatal D1 neuronsTrafficking and quality control of the gonadotropin releasing hormone receptor in health and diseaseEngineered protein connectivity to actin mimics PDZ-dependent recycling of G protein-coupled receptors but not its regulation by HrsOvercoming barriers to membrane protein structure determination.Regulated increase in folding capacity prevents unfolded protein stress in the ER.Chaperoning G protein-coupled receptors: from cell biology to therapeuticsProtein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavageAdenosine A2A receptor is involved in cell surface expression of A2B receptor.Progestin signaling through mPRα in Atlantic croaker granulosa/theca cell cocultures and its involvement in progestin inhibition of apoptosisUsing automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function.A single lys residue on the first intracellular loop modulates the endoplasmic reticulum export and cell-surface expression of α2A-adrenergic receptorOpioid receptor desensitization: mechanisms and its link to toleranceRecent advances on the δ opioid receptor: from trafficking to function.Prolonged morphine treatment alters δ opioid receptor post-internalization traffickingDi-acidic motifs in the membrane-distal C termini modulate the transport of angiotensin II receptors from the endoplasmic reticulum to the cell surface.Escorts take the lead molecular chaperones as therapeutic targetsMisrouted cell surface receptors as a novel disease aetiology and potential therapeutic target: the case of hypogonadotropic hypogonadism due to gonadotropin-releasing hormone resistance.Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking.Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors
P2860
Q21131288-955A71B7-BA0A-4567-B351-772D524FE959Q24301770-56D2650A-77EC-4579-A297-298A23CBE9D9Q24317093-A55EEB04-EE7C-4376-9733-99BBB2C11D29Q24317345-6604229B-3E65-4479-8DBE-C5B1579C52ADQ24318576-7016A500-514A-4B7B-9DC8-74C93A798793Q24319035-500F154E-B220-4EEE-8AE0-10861D5D8674Q24555191-43E543E8-5FDD-4E37-A5DF-1E46A56F98ABQ24657919-96C2DDFE-624B-4EF5-A93F-D1C745574DF0Q24680800-6D955D19-5BD5-4970-BEEA-361255BD0EF8Q24794484-727F84EC-EAB4-44A7-B87F-210F6A11A17BQ24804972-7C9BDE13-0400-44BE-A354-FC8EE3394124Q26858975-33E9874F-A459-46CE-88AC-105E3D862A64Q26866051-E52B92E5-6744-4031-B77C-9DA8ED81FC6FQ27001695-71528FD6-1304-4D5B-93C2-2D3801C1D98AQ27318901-3FAE5645-A90E-4D53-978B-FFAC4DF06674Q28390844-2663491D-9D77-46CB-A1CC-FFB788B2381FQ28392425-EB7F5976-89A7-416C-92EE-21600ABFB334Q28573360-27AC728F-3301-4CCF-BBA7-7FB0EDCF579BQ28574084-6EA67524-BBEB-4AC8-8AF8-631683F220B0Q28577566-9AB5E2D9-2F24-4799-A0DB-4C9F5BE1D328Q28593543-877D9283-FAB5-4E31-8183-12ECAEE66EBCQ28755163-9B383C5C-10B9-43B4-981B-FC51F3BEFD87Q28914742-32114FD6-A800-48BB-BA8D-613BB9EC250FQ30401692-5DA6F468-9867-4D29-8458-81F506D6F0EDQ30977675-3A555169-19A6-4D7A-9824-3D06F24ECD6FQ33927508-30F8D712-53FA-4A6A-B6ED-7203BA7E6065Q33949422-C8312D46-9505-42FF-BF79-852B4F382782Q34121376-EA5C963C-3A11-4515-9C37-E2F625CB3FB6Q34385959-3FB2C14B-D602-464E-9683-1DD023DA37E1Q34392583-B231737E-6C5A-4B98-A253-F359F9FD0225Q34494645-E08F01ED-F5FE-460B-B96A-87C563A9B32AQ34506992-82F498C7-B3BC-4F30-AEC7-85722D3B474EQ34729984-509BA3A2-A8C3-4A2C-848B-40736CCEFCD2Q34939664-F2525173-F198-48A2-8901-E872D030B261Q34939888-92699D56-7349-44DF-AA7F-03577D31FA7CQ35063290-81AFAC22-4BB3-4CED-A968-87A802182D68Q35075365-165983D0-B6F3-4FAA-8722-AB4635FDAF29Q35095132-BD89E970-2081-43E1-9B10-FCC27D817B4EQ35096287-7BA2ED66-CB22-4D16-A23C-E501295FFC10Q35606973-E916321C-760F-486C-B0A8-2ABB2AC443CC
P2860
Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor
description
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2000
@ast
im Mai 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/05/05)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/05/05)
@nl
наукова стаття, опублікована в травні 2000
@uk
name
Export from the endoplasmic re ...... he human delta opioid receptor
@ast
Export from the endoplasmic re ...... he human delta opioid receptor
@en
Export from the endoplasmic re ...... he human delta opioid receptor
@nl
type
label
Export from the endoplasmic re ...... he human delta opioid receptor
@ast
Export from the endoplasmic re ...... he human delta opioid receptor
@en
Export from the endoplasmic re ...... he human delta opioid receptor
@nl
prefLabel
Export from the endoplasmic re ...... he human delta opioid receptor
@ast
Export from the endoplasmic re ...... he human delta opioid receptor
@en
Export from the endoplasmic re ...... he human delta opioid receptor
@nl
P2093
P2860
P3181
P356
P1476
Export from the endoplasmic re ...... he human delta opioid receptor
@en
P2093
A. Laperriere
U. E. Petaja-Repo
P2860
P304
13727–13736
P3181
P356
10.1074/JBC.275.18.13727
P407
P577
2000-05-05T00:00:00Z